ASP 0113
Alternative Names: ASP-0113; ASP0113 CMV Therapeutic Vaccine; Cytomegalovirus DNA vaccine bivalent - Fresh Tracks Therapeutics; TransVax; VCL-CB01Latest Information Update: 05 Nov 2023
At a glance
- Originator Vical
- Developer Astellas Pharma
- Class Cytomegalovirus vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cytomegalovirus infections